This is a mobile optimized page that loads fast, if you want to load the real page, click this text.

ASX shockers

AKP 28/12/2016

A continuation of the pattern its been in since early August, stops triggering stops I'd say skc.
This is an example of where a weekly chart can sometimes shed more light on the trend.

(click to expand)
 
BAL 11/1/2016

There has been a few "reverse shockers" of late especially in the uranium space... but I am a bit too lazy to list them all here.
 
FOD was a 2016 shocker down 70% but is something of a reverse in the last couple of days.
 
2 profit downgrades today
ACX 30/1/2017
SRV 30/1/2017

And a mop up takeover bid
WCB 30/1/2017
 
IIL - No idea what they do, but look at that chart!

Research into MS. The only (maybe) viable drug for certain type of MS with a major study ending sometime before this June.

If the study result is positive, a big chance it'll be acquire by some major drug company. If it fails then down the tube it goes.

I saw it back last Oct but thought it's too risky as I know nothing about MS and with only one drug and no income so passed on it. That was when it's around $0.60s. I look pretty stupid as it goes to the $1.80s... not so stupid now but who knows how the study will turn out. I have a feeling it'll be positive but yea.

If it's any guide, John Rubino of MND was the top 20 shareholders couple of years ago. He could still be holding just others have skipped ahead of the holdings.
 
No idea why it went up 100% in Jan either. I guess one can only blame gravity.
In early January, they came out with a "forward-looking statement" about trials to combat MS. Someone may have an insight into the odds of success (or otherwise).



... and then there is the Trump effect that's holding even more successful Bio/ Pharma companies back. Maybe the cash transfer from $AUS to $USA wasn't such a good idea after all?
 
Who thought this list was going to get much longer. The next reporting season is going to be very interesting.

ACX blames Brexit and Trump. How pathetic.
 
Fall
VRT 31/1/2017
SLX 31/1/2017

Rise
IIL 31/1/2017
 
3 new shockers today
OFX 1/2/2017 Profit warning
GBT 1/2/2017 Profit warning
SEA 1/2/2017 Poor quarterly

2017 Count = 12.
 
Been watching NVT of late.. -9% YTD. Revenue down.
 
Cookies are required to use this site. You must accept them to continue using the site. Learn more...